Welireg 40mg 90 comprimés pelliculés

7680685310026 CH-68531 L01XX74
Welireg 40mg 90 comprimés pelliculés
Welireg 40mg 90 comprimés pelliculés
Welireg 40mg 90 comprimés pelliculés
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/08/2025
Patient information leaflet
Français
05/08/2025
Patient information leaflet
Italien
05/08/2025
Professional SmPC
Allemand
05/08/2025
Professional SmPC
Français
05/08/2025
Professional SmPC
Italien
05/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
1.356 MG Substance HBESI

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
68531
Drug name
Welireg, Filmtabletten
Galenic form
FILM
ATC Code
L01XX74
Authorization status
Z
Dispensation category
A
First authorization
21/03/2024
Authorization expiration date
30/06/2030
IT number
07.16.4.
Domain
Human medicine
Field of application
Von-Hippel-Lindau (VHL) - Krankheit, Fortgeschrittenes Nierenzellkarzinom (RCC)

Packaging details

Description (FR)
WELIREG cpr pellic 40 mg 90 pce
Description (DE)
WELIREG Filmtabl 40 mg 90 Stk
Market launch
01/11/2025
Narcotic (BTM)
No

Other packaging sizes

WELIREG cpr pellic 40 mg 90 pce
90 TABL
View